# Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation

> **NCT00122252** · — · TERMINATED · sponsor: **Alberta Health services** · enrollment: 20 (—)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00122252
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 20 (—)
- **Why stopped:** Study abandoned.
- **Last updated:** 2011-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00122252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00122252, "Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00122252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*